Zhou Y - Search Results

1

[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN.

Chen XE, Chen P, Chen SS, Ma T, Shi G, Zhou Y, Li J, Sheng L. Chen XE, et al. Among authors: zhou y. Oncol Rep. 2024 Jan;51(1):10. doi: 10.3892/or.2023.8669. Epub 2023 Nov 24. Oncol Rep. 2024. PMID: 37997815 Free PMC article.

2

A population association study of vitamin D receptor gene polymorphisms and haplotypes with the risk of systemic lupus erythematosus in a Chinese population.

Chen XE, Chen P, Chen SS, Lu J, Ma T, Shi G, Zhou Y, Li J, Sheng L. Chen XE, et al. Among authors: zhou y. Immunol Res. 2017 Jun;65(3):750-756. doi: 10.1007/s12026-017-8914-2. Immunol Res. 2017. PMID: 28285414

3

miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN.

Chen XΕ, Chen P, Chen SS, Ma T, Shi G, Zhou Y, Li J, Sheng L. Chen XΕ, et al. Among authors: zhou y. Oncol Rep. 2018 Jan;39(1):331-337. doi: 10.3892/or.2017.6099. Epub 2017 Nov 16. Oncol Rep. 2018. PMID: 29192321

4

MicroRNA‑30a controls the instability of inducible CD4+ Tregs through SOCS1.

Zhou Y, Li Y, Lu J, Hong X, Xu L. Zhou Y, et al. Mol Med Rep. 2019 Nov;20(5):4303-4314. doi: 10.3892/mmr.2019.10666. Epub 2019 Sep 10. Mol Med Rep. 2019. PMID: 31545427

5

MicroRNA-126: A new and promising player in lung cancer.

Chen Q, Chen S, Zhao J, Zhou Y, Xu L. Chen Q, et al. Among authors: zhou y. Oncol Lett. 2021 Jan;21(1):35. doi: 10.3892/ol.2020.12296. Epub 2020 Nov 12. Oncol Lett. 2021. PMID: 33262827 Free PMC article. Review.

6

MiR-7 deficiency promotes Th1 polarization of CD4⁺T cells and enhances the antitumor effect in adoptive cell therapy for lung cancer.

Chang X, Zhao J, Zhou Y, Guo M, Yan Y, Wang Y, Zhao X, Yang J, Chen C, Tang L, Qin M, Xu L. Chang X, et al. Among authors: zhou y. Immunol Res. 2024 Feb;72(1):134-146. doi: 10.1007/s12026-023-09423-y. Epub 2023 Sep 27. Immunol Res. 2024. PMID: 37755574

7

MicroRNA-7 overexpression positively regulates the CD8⁺ SP cell development via targeting PIK3R1.

Hu L, Zhou Y, Yang J, Zhao X, Mao L, Zheng W, Zhao J, Guo M, Chen C, He Z, Xu L. Hu L, et al. Among authors: zhou y. Exp Cell Res. 2021 Oct 15;407(2):112824. doi: 10.1016/j.yexcr.2021.112824. Epub 2021 Sep 10. Exp Cell Res. 2021. PMID: 34516985

8

The miR-7/EGFR axis controls the epithelial cell immunomodulation and regeneration and orchestrates the pathology in inflammatory bowel disease.

Zhao J, Guo M, Yan Y, Wang Y, Zhao X, Yang J, Chen J, Chen C, Tang L, Zeng W, Liu Y, Qin M, Zhou Y, Xu L. Zhao J, et al. Among authors: zhou y. J Adv Res. 2024 Mar;57:119-134. doi: 10.1016/j.jare.2023.04.011. Epub 2023 Apr 23. J Adv Res. 2024. PMID: 37094666 Free PMC article.

9

Mitochondria: a new intervention target for tumor invasion and metastasis.

Zhou Q, Cao T, Li F, Zhang M, Li X, Zhao H, Zhou Y. Zhou Q, et al. Among authors: zhou y. Mol Med. 2024 Aug 23;30(1):129. doi: 10.1186/s10020-024-00899-4. Mol Med. 2024. PMID: 39179991 Free PMC article. Review.

10

MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer.

Chen J, Yang J, Liu Y, Zhao X, Zhao J, Tang L, Guo M, Zhou Y, Chen C, Li D, Wen Z, Liang G, Xu L. Chen J, et al. Among authors: zhou y. Cancer Innov. 2024 Apr 16;3(3):e117. doi: 10.1002/cai2.117. eCollection 2024 Jun. Cancer Innov. 2024. PMID: 38947754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,996 results

Search Page

Filters